Stock Analysts’ Updated EPS Estimates for October, 7th (ASH, ATVI, AZZ, BBL, BPMC, CIR, CRL, CTRL, CUDA, EXEL)
Ashland (NYSE:ASH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Ashland Inc. is a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, personal care and pharmaceutical. Through their three commercial units – Ashland Specialty Ingredients, Ashland Performance Materials and Valvoline – they use good chemistry to make great things happen for customers in more than 100 countries. “
Activision Blizzard (NASDAQ:ATVI) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “ACTIVISION BLIZZARD, INC. is a worldwide pure-play online and console game publisher with leading market positions across all categories of the rapidly growing interactive entertainment software industry. Activision Blizzard’s portfolio includes best-selling video games such as Guitar Hero, Call of Duty, and Tony Hawk, as well as Spider-Man, X-Men, Shrek, James Bond and TRANSFORMERS, leading franchises such as Crash Bandicoot and Spyro and Blizzard Entertainment’s StarCraft, Diablo, and Warcraft franchises including the global number one subscription-based massively multi-player online role-playing game, World of Warcraft. Activision Blizzard maintains operations in the U.S., Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, Norway, Denmark, the Netherlands, Romania, Australia, Chile, India, Japan, China, the region of Taiwan and South Korea. “
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/stock-analysts-updated-eps-estimates-for-october-7th-ash-atvi-azz-bbl-bpmc-cir-crl-ctrl-cuda-exel.html
AZZ (NYSE:AZZ) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “AZZ Incorporated is an electrical equipment and components manufacturer serving the global growth markets of power generation, transmission and distribution, and industrial markets as well as a provider of hot dip galvanizing services to the steel fabrication market nationwide. “
BHP Billiton PLC (NYSE:BBL) had its sector perform rating reissued by analysts at RBC Capital Markets.
Blueprint Medicines Corp. (NASDAQ:BPMC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $31.00 price target on the stock. According to Zacks, “Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA. “
Circor International (NYSE:CIR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CIRCOR International, Inc. designs, manufactures and distributes valves and related products and services for use in a wide range of applications to optimize the efficiency or ensure the safety of fluid-control systems. The valves and related fluid-control products we manufacture are used in processing industries; oil and gas production, pipeline construction and maintenance; aerospace, military and commercial aircraft; pharmaceutical, medical and analytical equipment; and maritime manufacturing and maintenance. “
Charles River Laboratories International (NYSE:CRL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Charles River Laboratories is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies and has been in this business for more than 50 years. “
Control4 Corp. (NASDAQ:CTRL) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Control4 Corporation is engaged in providing automation and control solutions for the connected home. The Company offers home operating system that interacts with various music, video, lighting, temperature, security, and communications. It also provides 4Sight subscription services, which allow consumers to control and monitor their homes remotely from their smartphone, tablet, or laptop. Control4 Corporation is headquartered in Salt Lake City, Utah. “
Barracuda Networks (NYSE:CUDA) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $27.00 price target on the stock. According to Zacks, “Barracuda Networks, Inc. is engaged in designing and delivering security and storage solutions. Its products span three distinct markets, including: 1) content security, 2) networking and application delivery and 3) data storage, protection and disaster recovery. It offers cloud-connected solutions that help its customers address security threats, enhance network performance, and protect and store their data. Barracuda Networks, Inc. is headquartered in Campbell, California. “
Exelixis (NASDAQ:EXEL) had its outperform rating reaffirmed by analysts at Leerink Swann. The firm currently has a $15.00 target price on the stock.
Gigamon (NYSE:GIMO) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Gigamon Inc. is engaged in providing intelligent Traffic Visibility solutions for enterprises, data centers and service providers. Its products consist of GigaVUE, GigaSECURE, GigaSMART and GigaTAP products. The Company’s fabric enables information technology organizations to forward traffic from network infrastructure to management, analysis, and compliance and security tools. It has operations primarily in the United States, the rest of North America, Europe, the Middle East, Africa, and the Asia Pacific. Gigamon Inc. is headquartered in Milpitas, California. “
Golden Ocean Group (NASDAQ:GOGL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Golden Ocean Group Limited is a shipping company which engaged in the transportation of dry bulk cargoes. It operates primarily in the Capesize and Panamax market. Golden Ocean Group Limited, formerly known as Knightsbridge Shipping Limited, is based in HAMILTON, Bermuda. “
Ithaca Energy Inc Com Npv (OTCMKTS:IACAF) had its buy rating reissued by analysts at FinnCap.
International Consolidated Airlines Group SA (OTCMKTS:ICAGY) had its buy rating reiterated by analysts at Goldman Sachs Group Inc..
Immunomedics (NASDAQ:IMMU) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the company have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. They have recently licensed its lead product candidate, epratuzumab, to UCB, S.A. for the treatment of all autoimmune disease indications worldwide. “
Intermec (NYSE:IN) had its overweight rating reissued by analysts at Piper Jaffray Cos.. The firm currently has a $33.50 target price on the stock.
Intevac (NASDAQ:IVAC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $6.75 target price on the stock. According to Zacks, “Intevac, Inc. is a leading supplier of static sputtering systems and related manufacturing equipment used to manufacture thin-film disks for computer hard disk drives. Sputtering is a complex vacuum deposition process used to deposit multiple thin-film layers on a disk. The company’s primary objective is to be the industry leader in supplying disk sputtering equipment by providing disk sputtering systems which have both the highest overall performance and the lowest cost of ownership in the industry. “
The Medicines (NASDAQ:MDCO) had its buy rating reaffirmed by analysts at Jefferies Group. The firm currently has a $43.00 target price on the stock.
IMPINJ (NYSE:PI) had its outperform rating reaffirmed by analysts at RBC Capital Markets. The firm currently has a $37.00 price target on the stock, up from their previous price target of $30.00.
Tesla Motors (NASDAQ:TSLA) had its outperform rating reaffirmed by analysts at Robert W. Baird. They currently have a $338.00 price target on the stock.
Receive News & Ratings for Ashland Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland Inc and related companies with MarketBeat.com's FREE daily email newsletter.